Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
22%

OVERLAP
BY WEIGHT
18

# OF OVERLAPPING
HOLDINGS
SBIO
78
HOLDINGS
26%
ALSO IN BBP
BBP
67
HOLDINGS
29%
ALSO IN SBIO
SECTOR DRIFT (SBIO minus BBP)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in SBIO
Weight
in BBP
Overlap
AMICUS THERAPEUTICS INC 3.0% 2.1% 2.1%
MIRUM PHARMACEUTICALS, INC. 3.1% 1.9% 1.9%
TRAVERE THERAPEUTICS, INC. 1.7% 1.7% 1.7%
TARSUS PHARMACEUTICALS, INC. 1.9% 1.6% 1.6%
APELLIS PHARMACEUTICALS, INC. 1.6% 1.6% 1.6%
SBIO Overweight Relative to BBP
KYMERA THERAPEUTICS, INC. 4.2%
CELCUITY INC. 3.5%
CG ONCOLOGY, INC. 3.5%
ALKERMES PLC 3.1%
VIKING THERAPEUTICS, INC. 2.7%
APOGEE THERAPEUTICS, INC. 2.6%
DIANTHUS THERAPEUTICS INC 2.2%
EDGEWISE THERAPEUTICS, INC. 2.1%
SPYRE THERAPEUTICS INC 2.1%
DENALI THERAPEUTICS INC. 2.0%
SBIO Underweight Relative to BBP
DYNAVAX TECHNOLOGIES CORP -2.2%
IOVANCE BIOTHERAPEUTICS INC -1.9%
AXSOME THERAPEUTICS, INC. -1.9%
PHATHOM PHARMACEUTICALS, INC. -1.8%
BIOMARIN PHARMACEUTICAL INC -1.7%
HALOZYME THERAPEUTICS INC -1.7%
EXELIXIS INC -1.7%
REGENERON PHARMACEUTICALS -1.6%
INCYTE CORP -1.6%
AMGEN INC -1.6%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY